Yüklüyor......
吉非替尼治疗非小细胞肺癌的meta分析
BACKGROUND AND OBJECTIVE: Malignant grade and death rate are very high for non-small cell lung cancer, and geftinib is a new molecule target anticancer drug. The aim of this meta analysis is to evaluate the clinical efficacy and safety of geftinib for non-small cell lung cancer. METHODS: We searched...
Kaydedildi:
| Yayımlandı: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
中国肺癌杂志编辑部
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999715/ https://ncbi.nlm.nih.gov/pubmed/21496435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2011.04.09 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|